Exploring the relationship between environmental enteric dysfunction and oral vaccine responses

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 GBD Diarrhoeal Diseases Collaborators. Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Infect. Dis. 17(9), 909–948 (2017).
  MedlineGoogle Scholar
• 2 Liu L, Oza S, Hogan D et al. Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet 385(9966), 430–440 (2015).
  MedlineGoogle Scholar
• 3 GBD 2016 Disease and Injury Incidence and Prevalence Collaborators Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390(10100), 1211–1259 (2017).
  MedlineGoogle Scholar
• 4 VIEW-hub. Interactive mapping tool. www.view-hub.org/viz/.
  Google Scholar
• 5 Patel M, Shane AL, Parashar UD, Jiang B, Gentsch JR, Glass RI. Oral rotavirus vaccines: how well will they work where they are needed most? J. Infect. Dis. 200(Suppl. 1), S39–S48 (2009).
  MedlineGoogle Scholar
• 6 Plotkin SA, Lebrun A, Koprowski H. Vaccination with the CHAT strain of type 1 attenuated poliomyelitis virus in Leopoldville. Belgian Congo. 2. Studies of the safety and efficacy of vaccination. Bull. World Health Organ. 22, 215–234 (1960).
  Medline CASGoogle Scholar
• 7 Patriarca PA, Wright PF, John TJ. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev. Infect. Dis. 13(5), 926–939 (1991).
  Medline CASGoogle Scholar
• 8 Hallander HO, Paniagua M, Espinoza F et al. Calibrated serological techniques demonstrate significant different serum response rates to an oral killed cholera vaccine between Swedish and Nicaraguan children. Vaccine 21(1–2), 138–145 (2002).
  Medline CASGoogle Scholar
• 9 Armah GE, Sow SO, Breiman RF et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 376(9741), 606–614 (2010). •• Efficacy trial demonstrating the underperformance of oral rotavirus vaccine across three low income countries (Ghana, Kenya and Mali).
  Medline CASGoogle Scholar
• 10 Zaman K, Dang DA, Victor JC et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 376(9741), 615–623 (2010).
  Medline CASGoogle Scholar
• 11 Ruiz-Palacios GM, Perez-Schael I, Velazquez FR et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N. Engl. J. Med. 354(1), 11–22 (2006).
  Medline CASGoogle Scholar
• 12 Vesikari T, Matson DO, Dennehy P et al. Safety and efficacy of a pentavalent human–bovine (WC3) reassortant rotavirus vaccine. N. Engl. J. Med. 354(1), 23–33 (2006).
  Medline CASGoogle Scholar
• 13 Parker EP, Ramani S, Lopman BA et al. Causes of impaired oral vaccine efficacy in developing countries. Future Microbiol. 13, 97–118 (2017). •• Review summarising the risk factors for oral vaccine failure and the heterogeneous nature of the evidence available.
  Google Scholar
• 14 Moon SS, Tate JE, Ray P et al. Differential profiles and inhibitory effect on rotavirus vaccines of nonantibody components in breast milk from mothers in developing and developed countries. Pediatr. Infect. Dis. J. 32(8), 863–870 (2013).
  MedlineGoogle Scholar
• 15 Platts-Mills JA, Babji S, Bodhidatta L et al. Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED). Lancet Glob. Health 3(9), e564–e575 (2015).
  MedlineGoogle Scholar
• 16 Bucardo F, Nordgren J, Reyes Y, Gonzalez F, Sharma S, Svensson L. The Lewis A phenotype is a restriction factor for Rotateq and Rotarix vaccine-take in Nicaraguan children. Sci. Rep. 8(1), 1502 (2018).
  MedlineGoogle Scholar
• 17 Black RE, Victora CG, Walker SP et al. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet 382(9890), 427–451 (2013).
  MedlineGoogle Scholar
• 18 Smith MI, Yatsunenko T, Manary MJ et al. Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science 339(6119), 548–554 (2013).
  Medline CASGoogle Scholar
• 19 Smith LE, Stoltzfus RJ, Prendergast A. Food chain mycotoxin exposure, gut health, and impaired growth: a conceptual framework. Adv. Nutr. 3(4), 526–531 (2012).
  Medline CASGoogle Scholar
• 20 Prendergast A, Kelly P. Enteropathies in the developing world: neglected effects on global health. Am. J. Trop. Med. Hyg. 86(5), 756–763 (2012).
  MedlineGoogle Scholar
• 21 Campbell DI, Murch SH, Elia M et al. Chronic T cell-mediated enteropathy in rural west African children: relationship with nutritional status and small bowel function. Pediatr. Res. 54(3), 306–311 (2003). • Highlights the potential clinical importance of impaired gut barrier function in mediating stunting in infants in developing countries.
  MedlineGoogle Scholar
• 22 Veitch AM, Kelly P, Zulu IS, Segal I, Farthing MJ. Tropical enteropathy: a T-cell-mediated crypt hyperplastic enteropathy. Eur. J. Gastroenterol. Hepatol. 13(10), 1175–1181 (2001).
  Medline CASGoogle Scholar
• 23 Brewster DR, Manary MJ, Menzies IS, O'loughlin EV, Henry RL. Intestinal permeability in kwashiorkor. Arch. Dis. Child. 76(3), 236–241 (1997).
  Medline CASGoogle Scholar
• 24 Campbell DI, Elia M, Lunn PG. Growth faltering in rural Gambian infants is associated with impaired small intestinal barrier function, leading to endotoxemia and systemic inflammation. J. Nutr. 133(5), 1332–1338 (2003).
  Medline CASGoogle Scholar
• 25 Cook GC. Aetiology and pathogenesis of postinfective tropical malabsorption (tropical sprue). Lancet 1(8379), 721–723 (1984).
  Medline CASGoogle Scholar
• 26 Lindenbaum J, Alam AK, Kent TH. Subclinical small-intestinal disease in East Pakistan. Br. Med. J. 2(5530), 1616–1619 (1966).
  Medline CASGoogle Scholar
• 27 Chacko CJ, Paulson KA, Mathan VI, Baker SJ. The villus architecture of the small intestine in the tropics: a necropsy study. J. Pathol. 98(2), 146–151 (1969).
  Medline CASGoogle Scholar
• 28 Gerson CD, Kent TH, Saha JR, Siddiqi N, Lindenbaum J. Recovery of small-intestinal structure and function after residence in the tropics. II. Studies in Indians and Pakistanis living in New York City. Ann. Intern. Med. 75(1), 41–48 (1971).
  Medline CASGoogle Scholar
• 29 Lindenbaum J, Gerson CD, Kent TH. Recovery of small-intestinal structure and function after residence in the tropics. I. Studies in Peace Corps volunteers. Ann. Intern. Med. 74(2), 218–222 (1971).
  Medline CASGoogle Scholar
• 30 Lin A, Arnold BF, Afreen S et al. Household environmental conditions are associated with enteropathy and impaired growth in rural Bangladesh. Am. J. Trop. Med. Hyg. 89(1), 130–137 (2013).
  MedlineGoogle Scholar
• 31 Brown EM, Wlodarska M, Willing BP et al. Diet and specific microbial exposure trigger features of environmental enteropathy in a novel murine model. Nat. Commun. 6, 7806 (2015). • The first animal model of environmental enteric dysfunction (EED) which showed the importance of undernutrition and specific microbial exposure in recapitulating the intestinal pathology found in humans.
  Medline CASGoogle Scholar
• 32 Steiner TS, Lima AA, Nataro JP, Guerrant RL. Enteroaggregative Escherichia coli produce intestinal inflammation and growth impairment and cause interleukin-8 release from intestinal epithelial cells. J. Infect. Dis. 177(1), 88–96 (1998).
  Medline CASGoogle Scholar
• 33 Opintan JA, Newman MJ, Ayeh-Kumi PF et al. Pediatric diarrhea in southern Ghana: etiology and association with intestinal inflammation and malnutrition. Am. J. Trop. Med. Hyg. 83(4), 936–943 (2010).
  Medline CASGoogle Scholar
• 34 Roy SK, Behrens RH, Haider R et al. Impact of zinc supplementation on intestinal permeability in Bangladeshi children with acute diarrhoea and persistent diarrhoea syndrome. J. Pediatr. Gastroenterol. Nutr. 15(3), 289–296 (1992).
  Medline CASGoogle Scholar
• 35 Goto R, Panter-Brick C, Northrop-Clewes CA, Manahdhar R, Tuladhar NR. Poor intestinal permeability in mildly stunted Nepali children: associations with weaning practices and Giardia lamblia infection. Br. J. Nutr. 88(2), 141–149 (2002).
  Medline CASGoogle Scholar
• 36 Donowitz JR, Haque R, Kirkpatrick BD et al. Small intestine bacterial overgrowth and environmental enteropathy in Bangladeshi children. mBio 7(1), e02102–e02115 (2016).
  Medline CASGoogle Scholar
• 37 Fagundes Neto U, Martins MC, Lima FL, Patricio FR, Toledo MR. Asymptomatic environmental enteropathy among slum-dwelling infants. J. Am. Coll. Nutr. 13(1), 51–56 (1994).
  Medline CASGoogle Scholar
• 38 Ordiz MI, Stephenson K, Agapova S et al. Environmental enteric dysfunction and the fecal microbiota in Malawian children. Am. J. Trop. Med. Hyg. 96(2), 473–476 (2017).
  MedlineGoogle Scholar
• 39 Keusch GT, Denno DM, Black RE et al. Environmental enteric dysfunction: pathogenesis, diagnosis, and clinical consequences. Clin. Infect. Dis. 59(Suppl. 4), S207–S212 (2014). • Historical review of EED including description of four categories of aberrant gut structure and function.
  Medline CASGoogle Scholar
• 40 Kelly P, Menzies I, Crane R et al. Responses of small intestinal architecture and function over time to environmental factors in a tropical population. Am. J. Trop. Med. Hyg. 70(4), 412–419 (2004). • Evaluates mucosal architecture and function longitudinally and described associations with stool microbiology and environmental factors.
  MedlineGoogle Scholar
• 41 Papadia C, Kelly P, Caini S et al. Plasma citrulline as a quantitative biomarker of HIV-associated villous atrophy in a tropical enteropathy population. Clin. Nutr. 29(6), 795–800 (2010).
  Medline CASGoogle Scholar
• 42 Korpe PS, Petri WA Jr. Environmental enteropathy: critical implications of a poorly understood condition. Trends Mol. Med. 18(6), 328–336 (2012).
  MedlineGoogle Scholar
• 43 Serazin AC, Shackelton LA, Wilson C, Bhan MK. Improving the performance of enteric vaccines in the developing world. Nat. Immunol. 11(9), 769–773 (2010).
  Medline CASGoogle Scholar
• 44 Patel M, Glass RI, Jiang B, Santosham M, Lopman B, Parashar U. A systematic review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacy. J. Infect. Dis. 208(2), 284–294 (2013).
  Medline CASGoogle Scholar
• 45 Deming MS, Linkins RW, Jaiteh KO, Hull HF. The clinical efficacy of trivalent oral polio vaccine in The Gambia by season of vaccine administration. J. Infect. Dis. 175(Suppl. 1), S254–S257 (1997).
  MedlineGoogle Scholar
• 46 Keusch GT, Rosenberg IH, Denno DM et al. Implications of acquired environmental enteric dysfunction for growth and stunting in infants and children living in low- and middle-income countries. Food Nutr. Bull. 34(3), 357–364 (2013).
  MedlineGoogle Scholar
• 47 Petri WA Jr, Naylor C, Haque R. Environmental enteropathy and malnutrition: do we know enough to intervene? BMC Med. 12, 187 (2014).
  MedlineGoogle Scholar
• 48 Denno DM, Tarr PI, Nataro JP. Environmental enteric dysfunction: a case definition for intervention trials. Am. J. Trop. Med. Hyg. 97(6), 1643–1646 (2017).
  MedlineGoogle Scholar
• 49 Levine MM. Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine. BMC Biol. 8, 129 (2010).
  MedlineGoogle Scholar
• 50 Gilmartin AA, Petri WA Jr. Exploring the role of environmental enteropathy in malnutrition, infant development and oral vaccine response. Philos. Trans. R. Soc. Lond. B Biol. Sci. 370(1671), pii:20140143 (2015).
  MedlineGoogle Scholar
• 51 Becker-Dreps S, Vilchez S, Bucardo F et al. The association between fecal biomarkers of environmental enteropathy and rotavirus vaccine response in Nicaraguan infants. Pediatr. Infect. Dis. J. 36(4), 412–416 (2017). •• Evaluates immune responses to oral rotavirus vaccine in Nicaraguan infants with EED.
  MedlineGoogle Scholar
• 52 Grassly NC, Praharaj I, Babji S et al. The effect of azithromycin on the immunogenicity of oral poliovirus vaccine: a double-blind randomised placebo-controlled trial in seronegative Indian infants. Lancet Infect. Dis. 16(8), 905–914 (2016). •• In this randomized placebo controlled trial, azithromycin had no impact on oral polio vaccine immunogenicity but did reduce biomarkers of EED.
  Medline CASGoogle Scholar
• 53 Kosek MN, Mduma E, Kosek PS et al. Plasma tryptophan and the kynurenine–tryptophan ratio are associated with the acquisition of statural growth deficits and oral vaccine underperformance in populations with environmental enteropathy. Am. J. Trop. Med. Hyg. 95(4), 928–937 (2016). •• Evaluates immune responses to oral polio vaccine in Peruvian infants with EED, employing two novel biomarkers of EED.
  Medline CASGoogle Scholar
• 54 Lagos R, Fasano A, Wasserman SS et al. Effect of small bowel bacterial overgrowth on the immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR. J. Infect. Dis. 180(5), 1709–1712 (1999).
  Medline CASGoogle Scholar
• 55 Mwape I, Bosomprah S, Mwaba J et al. Immunogenicity of rotavirus vaccine (RotarixTM) in infants with environmental enteric dysfunction. PLoS ONE 12(12), e0187761 (2017). • Evaluates immune responses to oral rotavirus vaccine in Zambian children with EED.
  MedlineGoogle Scholar
• 56 Naylor C, Lu M, Haque R et al. Environmental enteropathy, oral vaccine failure and growth faltering in infants in Bangladesh. EBioMedicine 2(11), 1759–1766 (2015). •• Evaluates immune responses to oral polio and oral rotavirus vaccines in Bangladeshi infants with EED.
  MedlineGoogle Scholar
• 57 Uddin MI, Islam S, Nishat NS et al. Biomarkers of environmental enteropathy are positively associated with immune responses to an oral cholera vaccine in Bangladeshi children. PLoS Negl. Trop. Dis. 10(11), e0005039 (2016). •• Evaluates immune responses to oral cholera vaccine in Bangladeshi children with EED.
  MedlineGoogle Scholar
• 58 Prendergast AJ, Humphrey JH, Mutasa K et al. Assessment of environmental enteric dysfunction in the SHINE trial: methods and challenges. Clin. Infect. Dis. 61(Suppl. 7), S726–S732 (2015).
  Medline CASGoogle Scholar
• 59 Peterson KM, Guo X, Elkahloun AG et al. The expression of REG 1A and REG 1B is increased during acute amebic colitis. Parasitol. Int. 60(3), 296–300 (2011).
  Medline CASGoogle Scholar
• 60 Granlund A, Beisvag V, Torp SH et al. Activation of REG family proteins in colitis. Scand. J. Gastroenterol. 46(11), 1316–1323 (2011).
  MedlineGoogle Scholar
• 61 Crenn P, Messing B, Cynober L. Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction. Clin. Nutr. 27(3), 328–339 (2008).
  Medline CASGoogle Scholar
• 62 Prata MM, Havt A, Bolick DT, Pinkerton R, Lima A, Guerrant RL. Comparisons between myeloperoxidase, lactoferrin, calprotectin and lipocalin-2, as fecal biomarkers of intestinal inflammation in malnourished children. J. Transl. Sci. 2(2), 134–139 (2016).
  MedlineGoogle Scholar
• 63 Kosek M, Haque R, Lima A et al. Fecal markers of intestinal inflammation and permeability associated with the subsequent acquisition of linear growth deficits in infants. Am. J. Trop. Med. Hyg. 88(2), 390–396 (2013).
  MedlineGoogle Scholar
• 64 Guerrant RL, Leite AM, Pinkerton R et al. Biomarkers of environmental enteropathy, inflammation, stunting, and impaired growth in children in northeast Brazil. PLoS ONE 11(9), e0158772 (2016).
  MedlineGoogle Scholar
• 65 Kosek M, Guerrant RL, Kang G et al. Assessment of environmental enteropathy in the MAL-ED cohort study: theoretical and analytic framework. Clin. Infect. Dis. 59(Suppl. 4), S239–S247 (2014).
  Medline CASGoogle Scholar
• 66 Richard DM, Dawes MA, Mathias CW, Acheson A, Hill-Kapturczak N, Dougherty DM. L-tryptophan: basic metabolic functions, behavioral research and therapeutic indications. Int. J. Tryptophan. Res. 2, 45–60 (2009).
  Medline CASGoogle Scholar
• 67 Ciorba MA. Indoleamine 2,3 dioxygenase in intestinal disease. Curr. Opin. Gastroenterol. 29(2), 146–152 (2013).
  Medline CASGoogle Scholar
• 68 Gupta NK, Thaker AI, Kanuri N et al. Serum analysis of tryptophan catabolism pathway: correlation with Crohn's disease activity. Inflamm. Bowel Dis. 18(7), 1214–1220 (2012).
  MedlineGoogle Scholar
• 69 Lee S, Byakwaga H, Boum Y et al. Immunologic pathways that predict mortality in HIV-infected Ugandans initiating ART. J. Infect. Dis. 215(8), 1270–1274 (2017).
  Medline CASGoogle Scholar
• 70 Nikolaus S, Schulte B, Al-Massad N et al. Increased tryptophan metabolism is associated with activity of inflammatory bowel diseases. Gastroenterology 153(6), 1504.e2–1516.e2 (2017).
  Google Scholar
• 71 Riordan SM, Mciver CJ, Walker BM, Duncombe VM, Bolin TD, Thomas MC. The lactulose breath hydrogen test and small intestinal bacterial overgrowth. Am. J. Gastroenterol. 91(9), 1795–1803 (1996).
  Medline CASGoogle Scholar
• 72 Naylor C, Lu M, Haque R et al. Environmental enteropathy, oral vaccine failure and growth faltering in infants in Bangladesh. EBioMedicine 2(11), 1759–1766 (2015).
  MedlineGoogle Scholar
• 73 Church JPE, Kirkpatrick B, Grassly N, Prendergast AJ. Interventions to improve oral vaccine performance in developing countries: protocol for a systematic review and meta-analysis. (2017). www.crd.york.ac.uk/PROSPEROFILES/60608_PROTOCOL_20180108.pdf
  Google Scholar
• 74 Louis-Auguste J, Greenwald S, Simuyandi M, Soko R, Banda R, Kelly P. High dose multiple micronutrient supplementation improves villous morphology in environmental enteropathy without HIV enteropathy: results from a double-blind randomised placebo controlled trial in Zambian adults. BMC Gastroenterol. 14, 15 (2014).
  MedlineGoogle Scholar
• 75 Smith HE, Ryan KN, Stephenson KB et al. Multiple micronutrient supplementation transiently ameliorates environmental enteropathy in Malawian children aged 12–35 months in a randomized controlled clinical trial. J. Nutr. 144(12), 2059–2065 (2014).
  Medline CASGoogle Scholar
• 76 Wang AZ, Shulman RJ, Crocker AH et al. A combined intervention of zinc, multiple micronutrients, and albendazole does not ameliorate environmental enteric dysfunction or stunting in rural malawian children in a double-blind randomized controlled trial. J. Nutr. 147(1), 97–103 (2017).
  Medline CASGoogle Scholar
• 77 Trehan I, Benzoni NS, Wang AZ et al. Common beans and cowpeas as complementary foods to reduce environmental enteric dysfunction and stunting in Malawian children: study protocol for two randomized controlled trials. Trials 16, 520 (2015).
  MedlineGoogle Scholar
• 78 Jones KD, Hunten-Kirsch B, Laving AM et al. Mesalazine in the initial management of severely acutely malnourished children with environmental enteric dysfunction: a pilot randomized controlled trial. BMC Med. 12, 133 (2014).
  MedlineGoogle Scholar
• 79 Trehan I, Shulman RJ, Ou CN, Maleta K, Manary MJ. A randomized, double-blind, placebo-controlled trial of rifaximin, a nonabsorbable antibiotic, in the treatment of tropical enteropathy. Am. J. Gastroenterol. 104(9), 2326–2333 (2009).
  Medline CASGoogle Scholar
• 80 Galpin L, Manary MJ, Fleming K, Ou CN, Ashorn P, Shulman RJ. Effect of lactobacillus GG on intestinal integrity in Malawian children at risk of tropical enteropathy. Am. J. Clin. Nutr. 82(5), 1040–1045 (2005).
  Medline CASGoogle Scholar
• 81 Chattha KS, Vlasova AN, Kandasamy S, Rajashekara G, Saif LJ. Divergent immunomodulating effects of probiotics on T cell responses to oral attenuated human rotavirus vaccine and virulent human rotavirus infection in a neonatal gnotobiotic piglet disease model. J. Immunol. 191(5), 2446–2456 (2013).
  Medline CASGoogle Scholar
• 82 Maier EA, Weage KJ, Guedes MM et al. Protein-energy malnutrition alters IgA responses to rotavirus vaccination and infection but does not impair vaccine efficacy in mice. Vaccine 32(1), 48–53 (2013).
  Medline CASGoogle Scholar
• 83 Twitchell EL, Tin C, Wen K et al. Modeling human enteric dysbiosis and rotavirus immunity in gnotobiotic pigs. Gut Pathog. 8, 51 (2016).
  MedlineGoogle Scholar
• 84 Mckinley M, Leibowitz S, Bronzo R, Zanzi I, Weissman G, Schiffman G. Appropriate response to pneumococcal vaccine in celiac sprue. J. Clin. Gastroenterol. 20(2), 113–116 (1995).
  Medline CASGoogle Scholar
• 85 Sari S, Dalgic B, Basturk B, Gonen S, Soylemezoglu O. Immunogenicity of hepatitis A vaccine in children with celiac disease. J. Pediatr. Gastroenterol. Nutr. 53(5), 532–535 (2011).
  Medline CASGoogle Scholar
• 86 Schappi MG, Meier S, Bel M, Siegrist CA, Posfay-Barbe KM, Group HNS. Protective antibody responses to influenza A/H1N1/09 vaccination in children with celiac disease. J. Pediatr. Gastroenterol. Nutr. 54(6), 817–819 (2012).
  MedlineGoogle Scholar
• 87 Opri R, Veneri D, Mengoli C, Zanoni G. Immune response to Hepatitis B vaccine in patients with celiac disease: a systematic review and meta-analysis. Hum. Vaccin. Immunother. 11(12), 2800–2805 (2015).
  Medline CASGoogle Scholar
• 88 Beale AJ, Douglas AP, Parish WE, Hobbs JR. Impaired IgA responses in coeliac disease. Lancet 1(7711), 1198–1200 (1971).
  Medline CASGoogle Scholar
• 89 Mawhinney H, Love AH. The immunoglobulin class responses to oral poliovaccine in coeliac disease. Clin. Exp. Immunol. 21(3), 399–406 (1975).
  Medline CASGoogle Scholar
• 90 Burnham WR, Lennard-Jones JE, Hecketsweiler P, Colin R, Geffroy Y. Oral BCG vaccine in Crohn's disease. Gut 20(3), 229–233 (1979).
  Medline CASGoogle Scholar
• 91 Nguyen DL, Nguyen ET, Bechtold ML. Effect of immunosuppressive therapies for the treatment of inflammatory bowel disease on response to routine vaccinations: a meta-analysis. Dig. Dis. Sci. 60(8), 2446–2453 (2015).
  Medline CASGoogle Scholar
• 92 Mcgrath EJ, Thomas R, Duggan C, Asmar BI. Pentavalent rotavirus vaccine in infants with surgical gastrointestinal disease. J. Pediatr. Gastroenterol. Nutr. 59(1), 44–48 (2014).
  Medline CASGoogle Scholar
• 93 Kilhamn J, Brevinge H, Svennerholm AM, Jertborn M. Immune responses in ileostomy fluid and serum after oral cholera vaccination of patients colectomized because of ulcerative colitis. Infect. Immun. 66(8), 3995–3999 (1998).
  Medline CASGoogle Scholar
• 94 Factors affecting the immunogenicity of oral poliovirus vaccine: a prospective evaluation in Brazil and the Gambia. World Health Organization Collaborative Study Group on Oral Poliovirus Vaccine. J. Infect. Dis. 171(5), 1097–1106 (1995).
  MedlineGoogle Scholar
• 95 Cardemil CV, Estivariz C, Shrestha L et al. The effect of diarrheal disease on bivalent oral polio vaccine (bOPV) immune response in infants in Nepal. Vaccine 34(22), 2519–2526 (2016).
  Medline CASGoogle Scholar
• 96 Parker EP, Kampmann B, Kang G, Grassly NC. Influence of enteric infections on response to oral poliovirus vaccine: a systematic review and meta-analysis. J. Infect. Dis. 210(6), 853–864 (2014).
  Medline CASGoogle Scholar
• 97 Taniuchi M, Platts-Mills JA, Begum S et al. Impact of enterovirus and other enteric pathogens on oral polio and rotavirus vaccine performance in Bangladeshi infants. Vaccine 34(27), 3068–3075 (2016).
  MedlineGoogle Scholar
• 98 Harris VC, Armah G, Fuentes S et al. Significant correlation between the infant gut microbiome and rotavirus vaccine response in rural Ghana. J. Infect. Dis. 215(1), 34–41 (2017).
  Medline CASGoogle Scholar
• 99 Parker EPK, Praharaj I, Zekavati A et al. Influence of the intestinal microbiota on the immunogenicity of oral rotavirus vaccine given to infants in south India. Vaccine 36(2), 264–272 (2017).
  MedlineGoogle Scholar
• 100 Mccormick BJ, Lee GO, Seidman JC et al. Dynamics and trends in fecal biomarkers of gut function in children from 1–24 months in the MAL-ED study. Am. J. Trop. Med. Hyg. 96(2), 465–472 (2017).
  Medline CASGoogle Scholar
• 101 Angel J, Steele AD, Franco MA. Correlates of protection for rotavirus vaccines: possible alternative trial endpoints, opportunities, and challenges. Hum. Vaccin. Immunother. 10(12), 3659–3671 (2014).
  MedlineGoogle Scholar
• 102 Prendergast AJ, Rukobo S, Chasekwa B et al. Stunting is characterized by chronic inflammation in Zimbabwean infants. PLoS ONE 9(2), e86928 (2014).
  MedlineGoogle Scholar
• 103 Owino V, Ahmed T, Freemark M et al. Environmental enteric dysfunction and growth failure/stunting in global child health. Pediatrics 138(6), pii:e20160641 (2016).
  MedlineGoogle Scholar
• 104 Lu M, Zhou J, Naylor C et al. Application of penalized linear regression methods to the selection of environmental enteropathy biomarkers. Biomark. Res. 5, 9 (2017).
  MedlineGoogle Scholar